Effects of sulindac on arylamine N-acetyltransferase activity in human colon tumour cells

Cytobios

Volumn 1998, Issue 378, 1998, Pages 25-36

  Chang, S H ^a   Chung, J G ^a   Wu, L T ^a   Huang, L J ^a   Chen, S C ^a   Kuo, S C ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 aminofluorene; N acetyltransferase; P aminobenzoic acid; Sulindac

Indexed keywords

EID: 0002692157     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. BEAZER-BARCHY Y., Levy D. B., Moser A. R., Dove W. F., Hamilton S. R., Vogelstein B. and Kinzler K. W. 1996. Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis 17 1757-60.
2. BLUM M., Grant D. M., McBride O. W., Heim H. and Meyer U. A. 1990. Human arylamine N-acetyltransferase genes: isolation, characterization, chromosomal localization, and functional expression. DNA Cell Biol. 9 193-203.
3. BOOLBOL S. K., Dannenberg A. J., Chadburn A., Martucci C., Guo X. J., Ramonetti J. T., Abreu-Goris M., Newmark H. L., Lipkin M. L., DeCosse J. J. and Bertagnolli M. M. 1996. Cyclooxygenase-2 overexpression and tumour formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 56 2556-60.
4. BRADFORD M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72 248-54.
5. CARTWRIGHT R. A., Glasham R. W., Rogers H. J., Ahmed R. A., Barham-Hall D., Higgens E. and Kahn M. A. 1982. Role of N-acetyltransferase phenotype in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2 842-6.
6. CHEN G. W., Chung J. G., Hsieh C. L. and Lin J. G. 1998. Effects of garlic components diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in human colon tumor cells. Fd Chem. Toxicol. In press.
7. CHUNG J. G., Wang H. H., Tsou M. F., Hsieh S. E., Lo H. H., Yen Y. S., Chang S. S., Wu L.T., Lee J. H. and Hung C. F. 1997. Evidence for arylamine N-acetyltransferase activity in the bacterium Helicobacter pylori. Toxicol. Letters 91 63-71.
8. CLELAND W. W. 1967. The statistical analysis of enzyme kinetics data. Adv. Enzymol. 29 1-32.
9. EINISTO R, Watanabe M., Ishidate M. and Nohmi T. 1991. Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutat. Res. 259 95-102.
10. GIARDELLO F. M., Hamilton S. R., Krush A. J., Piantadosi S., Hylind L. M., Celano P., Booker S. V., Robinson C. R. and Offerhaus G. J. 1993. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. New Engl. J. Med. 328 1313-16.
11. GRANT D. M., Blum M., Beer M. and Meyer U. A. 1991. Monomorphic and polymorphic human arylamine N-acetyltransferase: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 39 184-91.
12. HANIF R., Pittas A., Feng Y., Koutsos M. I., Ziao L., Staiano-Coico L., Shiff S. I. and Rigas B. 1996. Effects of nonsteroidal antiinflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol. 52 237-45.
13. HEIN D. W., Doll M. A., Rustan T. D., Gray K., Feng Y., Ferguson R. J. and Grant D. W. 1993. Metabolic activation and detoxication of arylamine carcinogens by recombinant human NAT1 and NAT2 acetyltransferases. Carcinogenesis 14 1633-8.
14. HICKMAN D. and Sim E. 1991. N-acetyltransferase polymorphism: comparison of phenotype and genotype in humans. Biochem. Pharmacol. 42 1007-14.
15. ILETT K. F., David B. M., Detchon P., Castledon W. M. and Kwa R. 1987. Acetylator phenotype in colorectal carcinoma. Cancer Res. 47 1466-9.
16. JACOBY R. F., Marshall D. J., Newton M. A., Novakovic K., Tutsch K., Cole C. E., Lubet R. A., Kelloff G. J., Verma A., Moser A. R. and Dove W. F. 1996. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal antiinflammatory drug piroxicam. Cancer Res. 56 710-4.
17. KIRLIN W. G., Andrews A., Ogolla F., Yerokun T., Ferguson R. J. and Hein D. W. 1989a. Comparison of the polymorphic expression of N-acetyltransferase activity in human colon and bladder cytosol. Proc. Am. Assoc. Cancer Res. 30 160-6.
18. KIRLIN W. G., Trinidad A., Yerokun T., Ogolla F., Ferguson R. J., Andrews A. F., Brady P. K. and Hein D. W. 1989b. Polymorphic expression of acetyl-CoA-dependent arylamine N-acetyltransferase and acetyl-CoA-dependent O-acetyltransferase activation of N-hydroxyarylamines in human bladder cytosol. Cancer Res. 49 2448-54.
19. LADERO J. M., Gonzalez J. F., Benitez J. and Vargas E. 1991. Acetylator polymorphism in human colorectal carcinoma. Cancer Res. 51 2098-100.
20. LANG N. P., Chu D. Z. J., Hunter C. F., Kendall D. C., Flammang T. J. and Kadlubar F. F 1986. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg. 121 1259-61.
21. MINCHIN R. F., Reeves P. T., Teitel C. H., McManus M. E., Mojarrabi T., Ilett K. F. and Kadlubar F. F. 1992. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem. biophys. Res. Commun. 185 839-44.
22. OHSAKO S. and Deguchi T. 1990. Cloning and expression of cDNAs for polymorphic and monomorphic N-acetyltransferase from human liver. J. biol. Chem. 265 4630-4.
23. RAO C. V., Rivenson A., Simi B., Zang E., Kelloff G., Steele V. and Reddy B. S. 1995. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res. 55 1464-72.
24. REDDY B. S., Rao C. V. and Seibert K. 1996. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 56 4566-69.
25. REIDER M. J., Shear N. H., Kanee A., Tang B. K. and Spielberg S. P. 1991. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin. Pharmacol. Ther. 49 13-7.
26. ROBERT-THOMSON I. C., Ryan P., Khoo K. K., Hart W. J., McMichael A. J. and Burtler R. N. 1996. Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 347 1372-4.
27. VAN LIESHOUT E. M. M., Tiemessen D. M., Peters W. H. M. and Jansen J. B. M. 1998. Effects of nonsteroidal antiinflammatory drugs on glutathione S-transferase of the rat digestive tract. Carcinogenesis 18 485-90.
28. WADDWLL W. R. and Loughry R. W. 1983. Sulindac for polyposis of the colon. J. Surg. Oncol. 24 83-7.
29. WEBER W. W. and Hein D. W. 1985. N-acetylation pharmacogenetics. Pharmacol. Rev. 37 25-99.
30. WEBER W. W. 1987. The acetylator genes and drug response. Oxford University Press, New York. pp 21-55.